While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the ...

"Regardless of the insurance and of their access to prescription treatment, there are considerable risks associated with being a member of a racial and ethnic community, and increased risk of ...

Use of digital measurement tools to track individual adherence to treatment helped avoid raising doses or adding medications and improved adherence in patients with uncontrolled asthma, the INCA Sun ...

Did you know people with uncontrolled asthma go to the emergency room, urgent care, and need to be hospitalized more often for asthma-related emergencies? Uncontrolled asthma can cause your kids to ...

A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...

Lemanske RF, Mauger DT, Sorkness CA, et al, for the Childhood Asthma Research and Education (CARE) Network of the National, Heart, Lung, and Blood Institute. This study evaluated whether any of 3 ...

Please provide your email address to receive an email when new articles are posted on . 45% of children with airway eosinophils had endobronchial biopsy eosinophils without bronchoalveolar lavage ...

Associations between asthma and dementia differed based on the patient’s age and asthma control, according to a study ...

Medically reviewed by Daniel More, MD Key Takeaways GERD can worsen asthma symptoms, especially at night.Avoiding certain foods and not lying down after eating can help manage GERD.If GERD treatments ...

Nearly 90% of adults had maintenance OCS dose of 5mg/day or less after 52 weeks of treatment. HealthDay News — For adults with oral corticosteroid (OCS)-dependent severe uncontrolled asthma, ...

Patients with uncontrolled asthma had reduced symptoms and exacerbations with tezepelumab, according to a new study. Tezepelumab was effective in improving forced expiratory volume per 1 second (FEV 1 ...

Asthma diagram, lungs A post hoc analysis of the QUEST trial assessed clinical remission in patients with moderate-to-severe asthma after 24 and 52 weeks of dupilumab treatment. The following article ...